Skip to main content

Waypoint Capital Advisors, LLC

SEC CIK
0001905662
Latest filing
Oct 18, 2024

APGE holding history

Apogee Therapeutics, Inc. in every 13F filed by Waypoint Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APGE overviewAll 13F holders of APGEFull Q3 2024 holdings

Shares (Q3 2024)
627,089
Value
$36.8M
% of portfolio
7.8%
Quarters held
1
Since Q3 2024
Holdings of APGE by Waypoint Capital Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 2024627,089$36.8M7.8%+627,089NewHolders